NovoCure
NVCR
NVCR
236 hedge funds and large institutions have $1.24B invested in NovoCure in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 99 increasing their positions, 61 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more capital invested
Capital invested by funds: $1.19B → $1.24B (+$50.9M)
3% less funds holding
Funds holding: 243 → 236 (-7)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
236
Holding in Top 10
1
Calls
$16.7M
Puts
$5.74M
Top Buyers
| 1 | +$53.3M | |
| 2 | +$14.4M | |
| 3 | +$11.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.1M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.38M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$14.3M | |
| 3 | -$13.4M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$12.4M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$12.1M |
